Elim Pediatric Pharmaceuticals Inc. recognizes that children are not small adults; there are differences in the way in which drug is absorbed, distributed, metabolized and eliminated in children. Therefore, prediction of children dosage forms or dosing from adult data can be misleading and often life threatening. As a consequence, careful, age-appropriate formulation development is needed.

ElimPP Inc. formulation chemistry and pediatric study design will help facilitate the development of safe drug products for pediatric use. This is based on our knowledge of the effects of drugs and the delivery systems in pediatric patients. Elim does this with cognizance of our patient population and without compromising their well-being during and after the development.

ElimPP Inc. knows that both the drugs and the added ingredients must be properly selected. We follow the FDA and International harmonization guidelines to ensure that appropriate formulations are available for the pediatric population everywhere